Click to Share
 

Immunology Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12561323
By SMi Group
SMi's Immunogenicity will be returning to Holiday Inn Kensington Forum, London (13-14 June 2016) to discuss hot industry topics such as integration of immunogenicity risk data to forecast clinical outcomes, personalized cancer vaccine development
12452353
By SMi Group
SMi’s 4th annual Cancer Vaccines conference will be taking place on 16 - 17 September 2015 at the Marriott Regents Park in London, UK.
12368826
By Xeno Diagnostics, LLC
Addition of Top Talent Strengthens Fast-growing Indianapolis Biotech CRO
By Cambridge Healthtech Institute
Delegates now have the option to choose from 9 moderated breakout discussion groups on immunogenicity facilitated by industry and academic experts.
12300239
By SMi Group
In recent weeks, British drug company Circassia raised £200m on the London Stock Exchange to fund the commercial launch of a promising new cat allergy treatment, which was first developed by scientists at London’s Imperial College.
By Biotech Support Group
Delipidation of serum samples with Cleanascite™ and prevention of disease progression by inhibiting neutrophil extracellular trap (NET)
By Immunochemistry Technologies
Proper blocking of the unoccupied areas of the ELISA plate wells is paramount to reducing background noise and attaining an accurate result. The two new formulations offer researchers additional choices in reagents to optimize their ELISAs.
By AbboMax, Inc.
Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer, used as vehicles for drug delivery. AbboMax offers innovative liposome reagents with a large number of lipid compositions.
12147310
By MoBiTec GmbH, Germany
MoBiTec, a Germany based biotech company focused on products for life science, has entered into a distribution agreement with Bachem Americas, Inc., USA. Together with Bachem Americas, MoBiTec will continue to expand its portfolio of premier brands.
12140492
By Homeopathy World Community
Health Inn internet TV & radio show host Debby Bruck interviews Dr Golden on Monday May 20, 2013 to discuss latest data on vaccine damaged children and returning to health with alternative care, such as homeopathy, chelation, diet, and CEASE therapy
By KDM Communications
The Division of Infection and Immunity at Imperial College Healthcare NHS Trust is benefitting from a managed service contract with Abbott, ensuring an efficient and reliable service for one of Britain’s largest NHS trusts.
By GTCbio
Thomas Platts-Mills, will present‘The Significance of IgE Antibodies to Galactose-alpha -1, 3-Galactose (alpha-gal)’ at GTC’s 2nd Allergy & Respiratory Drug Discovery Conference taking place in San Diego, CA on January 31 – February 1, 2013.
11814389
By airmid healthgroup
airmid research team travel to the USA to present bio-medical research data related to indoor air quality and health at a world premiere medical event to expand knowledge in allergy, immunology and issues that relate to indoor air quality. .
By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.
By Dr Abubakar Yaro
This exciting event will bring together some of the leading TB researchers in the world to discuss the latest development in TB therapy.
By Cambridge Healthtech Institute
This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 17-18, 2011 at the DoubleTree Hotel in Bethesda, MD.

All Press Releases

By European Medical Journal
Welcome to the inaugural edition of EMJ Allergy & Immunology 1.1. The eJournal contains an array of scientific peer-reviewed articles that explore contemporary and global issues currently encountered in the field.
12561323
By SMi Group
SMi's Immunogenicity will be returning to Holiday Inn Kensington Forum, London (13-14 June 2016) to discuss hot industry topics such as integration of immunogenicity risk data to forecast clinical outcomes, personalized cancer vaccine development
By GeneTex
GeneTex offers an outstanding selection of antibodies to support immunoscience research.
By Roots Analysis
Roots Analysis has announced the addition of "Immune Checkpoint Inhibitors Market - 2014 - 2024" report to their offering.
By SMi Group
Discuss recent breakthroughs in the field of allergy therapeutics at SMi's 2nd annual Allergies conference, taking place on 8th and 9th July 2015 in London, UK.
12452353
By SMi Group
SMi’s 4th annual Cancer Vaccines conference will be taking place on 16 - 17 September 2015 at the Marriott Regents Park in London, UK.
By Cambridge Healthtech Institute
CHI, organizer of the 7th Annual Immunogenicity and Bioasssay Summit 2015, has issued a call for papers for those who would like to present at its event on Nov. 17-19, 2015 in Baltimore, MD. Submission deadline is May 7, 2015.
By MoBiTec GmbH
The latest edition of our MoBiTec Newsletter is now available for you to view. It comprises products for genomics & imaging, in vitro diagnostics and assays, interaction screening, magnetic beads as tool in proteomics, and Non-UV transilluminator.
12368826
By Xeno Diagnostics, LLC
Addition of Top Talent Strengthens Fast-growing Indianapolis Biotech CRO
By Dr. Barbara Baxter
Dr. Barbara Baxter, an experienced allergy doctor in Dallas, has launched a new website to better serve her current and potential patients.
By SMi Group
Health and Social Care Information Centre report a 7.7% Raise in Allergy Hospitalisation
By SMi Group
SMi is proud to announce that expert Ronit Mazor will be presenting about her study on “Identifying and removing T cell epitopes in immunotoxins” at the inaugural Immunogenicity Conference
By Cambridge Healthtech Institute
Delegates now have the option to choose from 9 moderated breakout discussion groups on immunogenicity facilitated by industry and academic experts.
12300239
By SMi Group
In recent weeks, British drug company Circassia raised £200m on the London Stock Exchange to fund the commercial launch of a promising new cat allergy treatment, which was first developed by scientists at London’s Imperial College.
By Biotech Support Group
Delipidation of serum samples with Cleanascite™ and prevention of disease progression by inhibiting neutrophil extracellular trap (NET)
By Immunochemistry Technologies
Proper blocking of the unoccupied areas of the ELISA plate wells is paramount to reducing background noise and attaining an accurate result. The two new formulations offer researchers additional choices in reagents to optimize their ELISAs.
By AbboMax, Inc.
Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer, used as vehicles for drug delivery. AbboMax offers innovative liposome reagents with a large number of lipid compositions.
12147310
By MoBiTec GmbH, Germany
MoBiTec, a Germany based biotech company focused on products for life science, has entered into a distribution agreement with Bachem Americas, Inc., USA. Together with Bachem Americas, MoBiTec will continue to expand its portfolio of premier brands.
12140492
By Homeopathy World Community
Health Inn internet TV & radio show host Debby Bruck interviews Dr Golden on Monday May 20, 2013 to discuss latest data on vaccine damaged children and returning to health with alternative care, such as homeopathy, chelation, diet, and CEASE therapy
By Immuno Biotech Ltd.
The conference will have talks by leading scientists and doctors from around the world and feature new research papers on the uses of GcMAF to restore the body’s immune system to full strength to fight diseases, autism and cancer.
By SMi Group
SMi’s highly respected Asthma & COPD conference returns to London and will bring you an esteemed panel of speakers from industry and academia with a packed agenda bursting with detail and insights from within the platforms of both Asthma & COPD.
By Rubriq
Announcing the launch of Rubriq, a new independent peer review system for scientific publishing. Rubriq is recruiting reviewers in all fields, and is now accepting papers in immunology, cancer biology and microbiology during the initial beta phase.
By SMi Group
This event will bring you an esteemed panel of speakers from industry and academia with a packed agenda bursting with detail and insights from within the platforms of both Asthma & COPD.
By KDM Communications
The Division of Infection and Immunity at Imperial College Healthcare NHS Trust is benefitting from a managed service contract with Abbott, ensuring an efficient and reliable service for one of Britain’s largest NHS trusts.
By GTCbio
Thomas Platts-Mills, will present‘The Significance of IgE Antibodies to Galactose-alpha -1, 3-Galactose (alpha-gal)’ at GTC’s 2nd Allergy & Respiratory Drug Discovery Conference taking place in San Diego, CA on January 31 – February 1, 2013.
By SMi Group
Difference between clinical development of vaccines and cytotoxic anti-cancer drugs
By Cambridge Healthtech Institute
With representation by Susan Kirshner, Jack Ragheb, Amy Rosenberg, and Daniela Verthelyi.
11814389
By airmid healthgroup
airmid research team travel to the USA to present bio-medical research data related to indoor air quality and health at a world premiere medical event to expand knowledge in allergy, immunology and issues that relate to indoor air quality. .
By Cambridge Healthtech Institute
Cambridge Healthtech Institute’s Third Annual Anti-Inflammatories: Small Molecule Approaches will be held April 17-18, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount expires January 27th.
By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share